hemophilia

BioMarin, Spark, raising the stakes for hemophilia
BioPharma Dive
Wed, 07/12/17 - 02:48 pm
Biomarin
Spark Therapeutics
hemophilia
BMN 270
SPK-9001
gene therapy
Shire blasts rival Roche for its “misleading” case for hemophilia trailblazer emicizumab
Motley Fool
Sun, 07/9/17 - 07:39 pm
Shire
Roche
hemophilia
emicizumab
Sanofi and Alnylam plunge into PhIII with a rival to Roche’s top hemophilia drug
Endpoints
Fri, 07/7/17 - 10:22 am
Sanofi
Alnylam
clinical trials
fitusiran
hemophilia
Roche
emicizumab
Pfizer expands gene therapy effort on hemophilia, bagging rights to a Sangamo drug in a $545M deal
Endpoints
Thu, 05/11/17 - 11:21 am
Pfizer
gene therapy
hemophilia
Sangamo BioSciences
SB-525
hemophilia A
Roche confirms patient death in ACE910 PhIII hemophilia trial, spurring new questions about top blockbuster hopeful
Endpoints
Fri, 02/24/17 - 11:39 am
Roche
ACE910
hemophilia
clinical trials
Biogen's hemophilia business spin-off will trade on its own starting Thursday
Marketwatch
Wed, 02/1/17 - 10:34 am
Biogen
spinoffs
Bioverativ
hemophilia
Biogen spinoff begins trading today; New oncology chief at AstraZeneca
Endpoints
Fri, 01/13/17 - 11:18 am
Biogen
AstraZeneca
oncology
hemophilia
Bioverativ
Spark Gets A Check From Pfizer And A Downgrade From Vetr
Yahoo/Benzinga
Fri, 01/6/17 - 09:50 am
Spark Therapeutics
Pfizer
hemophilia
Coming soon to the Nasdaq: Biogen's hemophilia spinoff
Bizjournals.com
Tue, 12/27/16 - 10:33 am
Biogen
NASDAQ
Bioverativ
spinoffs
hemophilia
Biogen Approves Spin-out of Hemophilia Business
TheStreet.com
Wed, 12/21/16 - 10:51 am
Biogen
spinoffs
hemophilia
Bioverativ
Alnylam touts hemophilia drug's edge over Roche rival
BioPharma Dive
Fri, 12/2/16 - 10:48 am
Alnylam
Roche
hemophilia
fitusiran
Safety issues with Roche drug good for Novo Nordisk
BioPharma Dive
Thu, 11/3/16 - 01:30 pm
Roche
Novo Nordisk
ACE910
emicizumab
hemophilia
Shire's new Baxalta hemophilia meds drop the ball in first combined quarter
Fierce Pharma
Wed, 11/2/16 - 09:56 am
Shire
Baxalta
hemophilia
earnings
Shire confident in hemophilia despite looming pricing challenge
BioPharma Dive
Tue, 11/1/16 - 04:55 pm
Shire
hemophilia
drug pricing
PBMs
Biogen's hemophilia business spinoff planned for early 2017
Marketwatch
Tue, 08/9/16 - 11:29 am
Biogen
spinoff
hemophilia
Bioverativ
Pfizer Inc, Sanofi SA (ADR) Could Eye Biogen’s Hemophilia Franchise
Bidness, ETC
Fri, 06/3/16 - 10:05 pm
Sanofi
Pfizer
Biogen
hemophilia
M&A
Could Shire Fancy Biogen’s Hemophilia Franchise
Bidness, ETC
Mon, 05/16/16 - 10:03 am
Shire
Biogen M&A
hemophilia
Why Biogen Is Hiving Off Its Hemophilia Business By Investopedia
Investopedia
Wed, 05/4/16 - 06:39 pm
Biogen
spinoffs
hemophilia
Biogen’s Hemophilia Spin: Prelude to a Takeover?
Barron's
Tue, 05/3/16 - 05:18 pm
Biogen
spinoffs
hemophilia
M&A
Biogen plans to spin off hemophilia drug business into a public company
Yahoo/Reuters
Tue, 05/3/16 - 10:20 am
Biogen
spinoffs
hemophilia

Pages